Amerika Serikat - Inggris - NLM (National Library of Medicine)

fresenius medical care north america - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698) - delflex® peritoneal dialysis solutions are indicated in the treatment of chronic renal failure patients being maintained on peritoneal dialysis when nondialytic medical therapy is judged to be inadequate. none known.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

fresenius medical care north america - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698) - delflex® peritoneal dialysis solutions are indicated in the treatment of chronic renal failure patients being maintained on peritoneal dialysis when nondialytic medical therapy is judged to be inadequate. none known.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (gluconic acid - unii:r4r8j0q44b, sodium cation - unii:lyr4m0nh37), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) ( magnesium cation - unii:t6v3lhy838, chloride ion - un - multiple electrolytes injection, type 1, usp, ph 7.4 is indicated as a source of water and electrolytes or as an alkalinizing agent. multiple electrolytes injection, type 1, usp, ph 7.4 is contraindicated in patients with a known hypersensitivity to the product. see warnings . for information on risk of air embolism – see dosage and administration. check solution container composition, lot number, and expiry date. parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. do not use solution containers in series connections. do not remove solution container from its overwrap until immediately before use. the intact port caps provide visual tamper evidence. do not use if a port cap is prematurely removed. maintain strict aseptic technique during handling. to open - always inspect the solution container before and after removal from the overwrap. - place the solution container on a clean, flat surface. using the

Amerika Serikat - Inggris - NLM (National Library of Medicine)

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium gluconate (unii: r6q3791s76) (gluconic acid - unii:r4r8j0q44b, sodium cation - unii:lyr4m0nh37), sodium acetate (unii: 4550k0sc9b) (acetate ion - unii:569dqm74sc, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - uni - multiple electrolytes injection, type 1, usp, ph 5.5 is indicated as a source of water and electrolytes or as an alkalinizing agent. multiple electrolytes injection, type 1, usp, ph 5.5 is contraindicated in patients with a known hypersensitivity to the product. see warnings . for information on risk of air embolism – see dosage and administration. check solution container composition, lot number, and expiry date. parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. do not use solution containers in series connections. do not remove solution container from its overwrap until immediately before use. the intact port caps provide visual tamper evidence. do not use if a port cap is prematurely removed. maintain strict aseptic technique during handling. to open - always inspect the solution container before and after removal from the overwrap. - place the solution container on a clean, flat surface. using the

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

viatris healthcare limited - pancreas powder ph. eur. - gastro-resistant capsule, hard - multienzymes (lipase, protease etc.)

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

viatris healthcare limited - pancreas powder ph. eur. - gastro-resistant capsule, hard - multienzymes (lipase, protease etc.)

Australia - Inggris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rutec pty ltd - phosphorus as mono-di potassium phosphite - liquid - phosphorus as mono-di potassium phosphite mineral-potassium active 400.0 g/l - fungicide - avocado | citrus - well established (see aliases) | citrus - young or small | grape | ornamental | pineapple | subterranean clov - downy mildew | phytophthora collar rot | phytophthora root rot | root rot - phytophthora spp. | soil fungi

Singapura - Inggris - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - tamoxifen citrate 15.2 mg eqv tamoxifen - tablet, film coated - 10 mg - tamoxifen citrate 15.2 mg eqv tamoxifen 10 mg

Singapura - Inggris - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - tamoxifen citrate 30.4mg eqv tamoxifen - tablet, film coated - 20 mg - tamoxifen citrate 30.4mg eqv tamoxifen 20 mg

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - pancreatic extract, quantity: 601.2 mg/g (equivalent: protease, qty 2000 ph eur unit; equivalent: amylase, qty 36000 ph eur unit; equivalent: lipase, qty 50000 ph eur unit) - granules, enteric-coated - excipient ingredients: hypromellose phthalate; cetyl alcohol; dimeticone 1000; macrogol 4000; triethyl citrate - creon micro is indicated as pancreatic enzyme replacement in paediatric and adult patients with pancreatic exocrine insufficiency (pei). pancreatic exocrine insufficiency is often associated with, but not limited to: cystic fibrosis, chronic pancreatitis, pancreatic surgery, gastrointestinal bypass surgery (eg. bilroth ii gastroenterostomy), ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).